These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23781134)

  • 1. Oxidative stress, DNA damage and repair in heart failure patients after implantation of continuous flow left ventricular assist devices.
    Mondal NK; Sorensen E; Hiivala N; Feller E; Griffith B; Wu ZJ
    Int J Med Sci; 2013; 10(7):883-93. PubMed ID: 23781134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress induced modulation of platelet integrin α2bβ3 expression and shedding may predict the risk of major bleeding in heart failure patients supported by continuous flow left ventricular assist devices.
    Mondal NK; Chen Z; Trivedi JR; Sorensen EN; Pham SM; Slaughter MS; Griffith BP; Wu ZJ
    Thromb Res; 2017 Oct; 158():140-148. PubMed ID: 28915447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Inflammatory Response Syndrome in End-Stage Heart Failure Patients Following Continuous-Flow Left Ventricular Assist Device Implantation: Differences in Plasma Redox Status and Leukocyte Activation.
    Mondal NK; Sorensen EN; Pham SM; Koenig SC; Griffith BP; Slaughter MS; Wu ZJ
    Artif Organs; 2016 May; 40(5):434-43. PubMed ID: 26416627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraplatelet reactive oxygen species, mitochondrial damage and platelet apoptosis augment non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist device.
    Mondal NK; Sorensen EN; Hiivala NJ; Feller ED; Pham SM; Griffith BP; Wu ZJ
    Platelets; 2015; 26(6):536-44. PubMed ID: 25167344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection, Oxidative Stress, and Changes in Circulating Regulatory T Cells of Heart Failure Patients Supported by Continuous-Flow Ventricular Assist Devices.
    Mondal NK; Sobieski MA; Pham SM; Griffith BP; Koenig SC; Slaughter MS; Wu ZJ
    ASAIO J; 2017; 63(2):128-133. PubMed ID: 27922883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant.
    Yuzefpolskaya M; Bohn B; Nasiri M; Zuver AM; Onat DD; Royzman EA; Nwokocha J; Mabasa M; Pinsino A; Brunjes D; Gaudig A; Clemons A; Trinh P; Stump S; Giddins MJ; Topkara VK; Garan AR; Takeda K; Takayama H; Naka Y; Farr MA; Nandakumar R; Uhlemann AC; Colombo PC; Demmer RT
    J Heart Lung Transplant; 2020 Sep; 39(9):880-890. PubMed ID: 32139154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insight of platelet apoptosis leading to non-surgical bleeding among heart failure patients supported by continuous-flow left ventricular assist devices.
    Mondal NK; Li T; Chen Z; Chen HH; Sorensen EN; Pham SM; Sobieski MA; Koenig SC; Slaughter MS; Griffith BP; Wu ZJ
    Mol Cell Biochem; 2017 Sep; 433(1-2):125-137. PubMed ID: 28343311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
    Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
    J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporary left ventricular assist devices as a bridge to heart transplantation.
    Seese L; Hickey G; Keebler ME; Mathier MA; Sultan I; Gleason TG; Wang Y; Kilic A
    J Card Surg; 2020 Apr; 35(4):810-817. PubMed ID: 32092194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet glycoprotein Ibα ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices.
    Hu J; Mondal NK; Sorensen EN; Cai L; Fang HB; Griffith BP; Wu ZJ
    J Heart Lung Transplant; 2014 Jan; 33(1):71-9. PubMed ID: 24055626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise performance of chronic heart failure patients in the early period of support by an axial-flow left ventricular assist device as destination therapy.
    Compostella L; Russo N; Setzu T; Compostella C; Bellotto F
    Artif Organs; 2014 May; 38(5):366-73. PubMed ID: 24117945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrovascular and microvascular function after implantation of left ventricular assist devices in end-stage heart failure: Role of microparticles.
    Sansone R; Stanske B; Keymel S; Schuler D; Horn P; Saeed D; Boeken U; Westenfeld R; Lichtenberg A; Kelm M; Heiss C
    J Heart Lung Transplant; 2015 Jul; 34(7):921-32. PubMed ID: 25980571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Oxidative Stress and Platelet Receptor Glycoprotein GPIbα and GPVI Shedding During Nonsurgical Bleeding in Heart Failure Patients With Continuous-Flow Left Ventricular Assist Device Support.
    Mondal NK; Chen Z; Trivedi JR; Sorensen EN; Pham SM; Slaughter MS; Griffith BP; Wu ZJ
    ASAIO J; 2018; 64(4):462-471. PubMed ID: 28953486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful continuous-flow left ventricular assist device implantation with adjuvant tricuspid valve repair for advanced heart failure.
    Lee CH; Wei J
    Cardiovasc J Afr; 2016 Jul/Aug 23; 27(4):e14-e16. PubMed ID: 27080526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First results of HeartWare left ventricular assist device implantation with tunnelling of the outflow graft through the transverse sinus.
    Hanke JS; Rojas SV; Cvitkovic T; Wiegmann B; Horke A; Warnecke G; Haverich A; Schmitto JD
    Interact Cardiovasc Thorac Surg; 2017 Oct; 25(4):503-508. PubMed ID: 28962493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of inflammation in recipients of continuous-flow left ventricular assist devices.
    Grosman-Rimon L; McDonald MA; Jacobs I; Tumiati LC; Pollock Bar-Ziv S; Shogilev DJ; Mociornita AG; Ghashghai A; Chruscinski A; Cherney DZ; Rao V
    ASAIO J; 2014; 60(6):657-63. PubMed ID: 25232767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurohormonal regulation and improvement in blood glucose control: reduction of insulin requirement in patients with a nonpulsatile ventricular assist device.
    Koerner MM; El-Banayosy A; Eleuteri K; Kline C; Stephenson E; Pae W; Ghodsizad A
    Heart Surg Forum; 2014 Apr; 17(2):E98-102. PubMed ID: 24808450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices.
    Mohamedali B; Yost G; Bhat G
    J Card Fail; 2015 Oct; 21(10):800-5. PubMed ID: 26093334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.